Management tracks: Prometic, Synlogic

Prometic Life Sciences Inc. (TSX:PLI; OTCQX:PFSCF) board member and CEO Pierre Laurin stepped down to pursue other opportunities. Chairman Simon Best was named interim CEO while the fibrosis and orphan disease company searches for a new CEO.

Synlogic Inc. (NASDAQ:SYBX) terminated the employment of Andrew Gengos, COO and head of corporate development, without cause, effective Jan. 15. In an SEC filing, the synthetic biology company said Gengos' role had been materially diminished. ...